🔎 Trials Near Me

Hjem › Metastatisk cancer › Texas › Austin

Metastatisk cancer kliniske forsøg i Austin, TX

19 studier for Metastatisk cancer søger deltagere på steder i og omkring Austin (inden for ca. 30 miles). Åbn et studie for at se, hvem der kan deltage, og hvordan man kontakter studieteamet.

Officiel studietekst (engelsk)

Rekrutterer til et studie her? Få det vist øverst på siden — $99 i 30 dage →

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

RekruttererFase 1/2
  • New Experimental Therapeutics - NEXT Oncology, Austin
Alder 12 og opefter · Alle køn · Opdateret 2. okt. 2026 · NCT04585750

Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma

RekruttererFase 3
  • Texas Oncology - Austin, Austin
Alder 18 og opefter · Alle køn · Opdateret 2. okt. 2026 · NCT07562152

A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors

RekruttererFase 1
  • NEXT Austin, Austin
Alder 18 og opefter · Alle køn · Opdateret 2. okt. 2026 · NCT06270706

A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors

RekruttererFase 1
  • NEXT Oncology, Austin
Alder 19 og opefter · Alle køn · Opdateret 1. okt. 2026 · NCT06586957

Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer

RekruttererFase 3
  • Texas Oncology - Central/South Texas, Austin
Alder 18 og opefter · Alle køn · Opdateret 25. sep. 2026 · NCT07222566

A Study of NEOK001, a B7-H3 and ROR1 Targeting Bispecific ADC in Participants With Select Solid Tumors

RekruttererFase 1
  • NEXT Oncology, Austin
Alder 18 og opefter · Alle køn · Opdateret 25. sep. 2026 · NCT07612176

A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract

RekruttererFase 3
  • USO-Texas Oncology-Central/South Texas, Austin
Alder 18 og opefter · Alle køn · Opdateret 22. sep. 2026 · NCT07218380

A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer

RekruttererFase 3
  • USO-Texas Oncology-Central/South Texas, Austin
Alder 18 og opefter · Alle køn · Opdateret 22. sep. 2026 · NCT07213804

Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer

RekruttererFase 1/2
  • Texas Oncology (Balcones) - SCRI, Austin
Alder 18 og opefter · Alle køn · Opdateret 18. sep. 2026 · NCT05267626

Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer

RekruttererFase 1/2
  • Texas Oncology - Central South, Austin
  • Texas Oncology - Central South, Austin
  • Texas Oncology - Central South, Austin
  • og 1 flere
Alder 18 og opefter · Alle køn · Opdateret 17. sep. 2026 · NCT07227415

Study of ISM6331 in Participants With Advanced/Metastatic Mesothelioma or Other Advanced Solid Tumors

RekruttererFase 1/2
  • NEXT Oncology - Austin, Austin
Alder 18 og opefter · Alle køn · Opdateret 16. sep. 2026 · NCT06566079

A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

RekruttererFase 3
  • USO - Texas Oncology, Austin
Alder 18 og opefter · Alle køn · Opdateret 8. sep. 2026 · NCT06119581

BEACON-1: Study of AVZO-103 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Urothelial Cancer or Other Solid Tumors (AVZO-103-1001)

RekruttererFase 1/2
  • Avenzo Therapeutics Recruiting Site, Austin
Alder 18 og opefter · Alle køn · Opdateret 25. aug. 2026 · NCT07193511

A Study to Investigate Safety and Effectiveness of CRN09682 in Participants With SST2-Expressing NENs and Other Solid Tumors

RekruttererFase 1/2
  • Crinetics Study Site, Austin
Alder 18 og opefter · Alle køn · Opdateret 31. jul. 2026 · NCT07129252

A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors

RekruttererFase 1/2
  • Texas Oncology - Central/South Texas, Austin
Alder 18 og opefter · Alle køn · Opdateret 30. jul. 2026 · NCT04657068

Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)

RekruttererFase 3
  • Research Site, Austin
Alder 18 og opefter · Kvinder · Opdateret 29. jul. 2026 · NCT07044336

A Study of CHS-114 (Tagmokitug) in Combination With Toripalimab and/or Other Treatments in Participants With Advanced Solid Tumors

RekruttererFase 1
  • Texas Oncology - Central South, Austin
Alder 18 og opefter · Alle køn · Opdateret 15. jul. 2026 · NCT06657144

Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS

RekruttererFase 1/2
  • University of Texas at Austin, Austin
Alder 18 og opefter · Alle køn · Opdateret 15. maj 2026 · NCT05379985

A Study of OR502, a Monoclonal Antibody Targeting LILRB2, Alone and in Combination With Anticancer Agents

RekruttererFase 1/2
  • NEXT Austin, Austin
Alder 18 og opefter · Alle køn · Opdateret 7. jan. 2025 · NCT06090266

Metastatisk cancer forsøg i andre byer

Andre studier i Austin

Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.